Evaluate Efficacy News Today

Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label...

Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label data to be presented at a future medical meeting2

Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The

Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The

The AccessLex Institute® funds will extend the U of A School of Law’s ongoing support of underrepresented and marginalized students who are preparing for law school.

Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid in IPFAdditional presentations include preclinical and translational data...

Vicore Announces Presentations at the 2024 American Thoracic Society ...

Gepotidacin was compared with the combination of ceftriaxone and azithromycin in adolescent and adult patients with uncomplicated urogenital gonorrhea.

Receipt of RZV was not associated with an increased risk of incident gout among more than 1,000 adults ≥ 65 years of age who received at least 1 dose of the 2-dose vaccine regimen.

Each year, service awards and program recognitions are presented as ASDS members celebrate recent achievements and successes....